Related Experiment Videos

Cardiovascular disease in diabetic nephropathy patients: cell adhesion molecules as potential markers?

Ted Wu1, Kristine C Y McGrath, Alison K Death

  • 1The Heart Research Institute, Camperdown, NSW, Australia.

Vascular Health and Risk Management
|February 24, 2007
PubMed

Insights

Diabetic kidney disease increases cardiovascular disease risk through cell adhesion molecules. Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 are key factors in atherosclerosis development in these patients.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Endocrinology

Background:

  • Cardiovascular disease (CVD) is a significant complication in diabetes mellitus, particularly in patients with diabetic nephropathy.
  • The pathogenic mechanisms linking diabetic nephropathy and CVD remain unclear.
  • Endothelial cell adhesion molecules (ICAM-1, VCAM-1) are implicated in atherosclerosis initiation.

Purpose of the Study:

  • To review the role of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in cardiovascular disease pathogenesis.
  • To explore the link between diabetic nephropathy and cardiovascular disease through these adhesion molecules.

Main Methods:

  • Literature review focusing on cell adhesion molecules in diabetes and nephropathy.
  • Analysis of studies investigating ICAM-1 and VCAM-1 levels in diabetic patients with kidney disease.

Main Results:

  • Elevated levels of ICAM-1 and VCAM-1 are observed in both diabetic and kidney disease states.
  • These adhesion molecules play a critical role in the early stages of atherosclerosis.

Conclusions:

  • ICAM-1 and VCAM-1 are likely key contributors to cardiovascular disease in patients with diabetes and diabetic nephropathy.
  • Understanding these mechanisms may lead to targeted therapies for cardiovascular complications.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...